Keyora LungOra 8 in 1: Three-Axis, Six-Module Nutritional Pharmacology Framework for Respiratory Disorders

0009-0007-5798-1996 DOI: 10.17605/OSF.IO/URVE7
Description
Wiki

Background and Rationale

Respiratory disorders - including acute viral infections, asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis - share a convergent pathobiology characterized by insufficient antiviral defense, uncontrolled inflammatory–oxidative loops, impaired barrier integrity, and inadequate elastic-network repair under systemic metabolic stress.

Conventional single-target nutrition rarely closes this multi-stage loop, highlighting the need for a systems-based nutritional pharmacology model.

Framework Overview

This project presents Keyora Three-Axis, Six-Module Framework for dietary nutritional intervention in respiratory disorders:

1. Axis I – Antiviral and Immune-Regulatory Axis

（1）Module I – Antiviral Defense: Targeting viral entry and replication through bioactive nutrients with zinc-ionophore activity and glycoprotein-binding blockade.

（2）Module II – Inflammation, Inflammasome, and Allergy Regulation: Nutritional suppression of inflammasome activation, NF-κB signaling, and allergic responses, preventing uncontrolled immune amplification.

2. Axis II – Antioxidant–Barrier Homeostasis Axis

(3 ) Module III – Antioxidant Defense and Barrier Integrity: Multi-nutrient synergy that buffers oxidative stress, stabilizes epithelial junctions, and preserves mucosal barriers against chronic injury.

3. Axis III – Ventilation–Structure–Metabolism Axis

(4) Module IV – Mucociliary Dynamics and Ventilation Improvement: Enhancing airway clearance and reducing mucus obstruction through anti-inflammatory and mucoregulatory actions.

(5) Module V – Structural Repair and Elastic-Network Reconstruction: Providing essential substrates (e.g., elastin-specific amino acids) for extracellular matrix (ECM) rebuilding and restoring alveolar–vascular flexibility and compliance.

(6) Module VI – Metabolism–Inflammation Coupling and Systemic Noise Reduction: Breaking the vicious cycle of metabolic stress and inflammatory signaling, thereby reducing long-term fibrotic remodeling and systemic burden.

Clinical Implications

This Keyora framework delivers a full-chain protective continuum - from acute-phase antiviral defense and inflammation control, through subacute antioxidant buffering and barrier stabilization, to long-term structural repair and systemic homeostasis . It offers a structured model for nutritional pharmacology that can be applied across different respiratory conditions and populations, including acute infection recovery, chronic disease management, and aging-related pulmonary decline.

Objective

This OSF project aims to consolidate mechanistic evidence and clinical research into a unified systems-nutrition framework for respiratory health. By integrating multi-nutrient interventions into the Three-Axis, Six-Module model, the project seeks to provide a replicable academic reference and a practical basis for future clinical nutrition strategies.

Project Title

Keyora LungOra 8 in 1: Three-Axis, Six-Module Nutritional Pharmacology Framework for Respiratory Disorders

Background and Rationale

Respiratory disorders - from acute viral infections to asthma, COPD, and pulmonary fibrosis - share convergent mechanisms: early deficits in antiviral defense, amplification of inflammation–oxidation loops, loss of epithelial barrier integrity, and insufficient elastic-network repair under chronic metabolic stress.

Single-target nutrition rarely closes this multi-stage loop. This project formalizes a systems-nutrition model to address the full course of disease.

Framework Overview: Three Axes, Six Modules

Axis I – Antiviral and Immune-Regulatory Axis

  • Module I – Antiviral Defense:

Interception of viral attachment/entry and replication; reinforcement of innate antiviral signaling to reduce early viral load.

  • Module II – Regulation of Inflammation, Inflammasome, and Allergic Responses:

Down-shift of NF-κB/inflammasome activity and allergic reactivity to prevent immune over-amplification and airway damage.

Axis II – Antioxidant–Barrier Homeostasis Axis

  • Module III – Antioxidant Defense and Barrier Integrity:

Multi-nutrient antioxidant buffering of ROS/RNS, stabilization of
tight junctions, preservation of mucosal/vascular barriers, and
reduction of oxidative–inflammatory stress across acute and chronic
phases.

Axis III – Ventilation–Structure–Metabolism Axis

  • Module IV – Mucociliary Dynamics and Ventilation Improvement:

Anti-inflammatory and mucoregulatory actions to restore airflow, reduce mucus plugging, and enhance gas exchange efficiency.

  • Module V – Structural Repair and Elastic-Network Reconstruction:

Provision of elastin-specific building blocks and cofactors to shift repair from rigid collagen patching toward flexible, functional alveolar–vascular network rebuilding.

  • Module VI – Metabolism–Inflammation Decoupling and Systemic Noise Reduction:

Breaking the vicious cycle linking metabolic stress with inflammatory signaling to lower long-term fibrotic risk and systemic burden.

Clinical Implications

The Keyora framework delivers a full-chain continuum:

  • Acute phase: antiviral interception, inflammation suppression, oxidative buffering → lower severity.
  • Subacute repair: antioxidant protection, barrier stabilization, improved ventilation → faster, higher-quality recovery.
  • Chronic/aging phases: ECM rebuilding and systemic homeostasis →
    sustained function and slower structural decline.

Objectives

  1. Codify an evidence-based, mechanism-mapped model for nutritional pharmacology in respiratory disorders.
  2. Provide a replicable template for study design, outcome selection (symptoms, lung function, imaging, biomarkers), and staged intervention logic.
  3. Enable translational use in acute recovery, chronic disease management, and prevention in at-risk populations.

Keywords

Acute respiratory infections; Influenza; COVID-19; Asthma; Chronic obstructive pulmonary disease (COPD); Post-viral sequelae; Pulmonary fibrosis; Antiviral defense; Innate immune activation; Inflammasome modulation; Anti-allergic regulation; Antioxidant buffering; Barrier stabilization; Mucociliary clearance; Ventilation improvement; Extracellular-matrix repair; Elastic-network reconstruction; Metabolism-inflammation decoupling; Systemic noise reduction; Viral entry and replication; Cytokine amplification; Oxidative stress; Epithelial/endothelial leak; Mucus hyper-viscosity; Airflow limitation; Loss of pulmonary compliance; Low-quality fibrotic repair; AGE–RAGE–driven inflammation; Metabolic dysregulation; Prolonged recovery trajectory.